Moreover, WNT5A expression showed downregulation in five cancer types, including esophageal carcinoma (ESCA) (num(T) = 184; num(N) = 11), kidney chromophobe (KICH) (num(T) = 66; num(N) = 25), kidney renal clear cell carcinoma (KIRC) (num(T) = 533; num(N) = 72), prostate adenocarcinoma (PRAD) (num(T) = 497; num(N) = 52), and uterine corpus endometrial carcinoma (num(T) = 545; num(N) = 35) (Figure 1B). Here, WNT5A is linked to prostate adenocarcinoma.